Athens Medical C.S.A Valuation

Q: What is the Fair Price of IATR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

IATR (€1.51) is trading above our estimate of [[fair value]] (€0.09)

Is IATR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of IATR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: IATR (€1.51) is trading above our estimate of fair value (€0.09)

Significantly Below Fair Value: IATR is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for IATR?

Key metric: As IATR is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for IATR. This is calculated by dividing IATR's market cap by their current earnings.
What is IATR's PE Ratio?
PE Ratio	14.4x
Earnings	€9.07m
Market Cap	€130.97m

IATR key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1x
Enterprise Value/EBITDA	7.6x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does IATR's PE Ratio compare to its peers?

The above table shows the PE ratio for IATR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	71.4x
PHG Patrangsit Healthcare Group	15.8x	11.6%	฿4.6b
ENE Centrum Medyczne ENEL-MED	80.2x	n/a	zł559.9m
NTV Nonthavej Hospital	12.9x	n/a	฿5.0b
BMHS Bundamedik	176.7x	n/a	Rp2.3t
IATR Athens Medical C.S.A	14.4x	n/a	€131.0m

Price-To-Earnings vs Peers: IATR is good value based on its Price-To-Earnings Ratio (14.4x) compared to the peer average (71.4x).

Price to Earnings Ratio vs Industry

How does IATR's PE Ratio compare vs other companies in the European Healthcare Industry?

2 Companies	Price / Earnings	Estimated Growth	Market Cap

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: IATR is good value based on its Price-To-Earnings Ratio (14.4x) compared to the European Healthcare industry average (18.5x).

Price to Earnings Ratio vs Fair Ratio

What is IATR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IATR PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	14.4x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate IATR's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.